🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/01/2005 41,80 44,00 40,00 42,50 +1,67% 9,57% 8.310
06/01/2005 38,00 41,90 38,00 41,80 +10,00% 10,26% 6.370
05/01/2005 37,90 39,50 37,80 38,00 -2,56% 4,49% 4.320
04/01/2005 43,50 43,50 36,70 39,00 -2,50% 15,63% 15.630
03/01/2005 43,40 43,40 40,00 40,00 -7,41% 7,83% 5.210
31/12/2004 46,40 46,40 43,20 43,20 -3,14% 6,90% 5.460
30/12/2004 45,00 45,80 43,35 44,60 -0,89% 5,44% 6.690
29/12/2004 46,00 46,00 43,33 45,00 -0,44% 5,80% 3.430
28/12/2004 45,60 46,10 44,26 45,20 -1,53% 4,04% 5.430
27/12/2004 45,90 46,00 44,70 45,90 +0,83% 2,83% 3.740
23/12/2004 48,50 48,50 44,00 45,52 -0,83% 9,28% 18.450
22/12/2004 45,90 47,50 43,20 45,90 +6,50% 9,37% 15.750
21/12/2004 45,00 46,50 42,80 43,10 -2,05% 8,22% 15.030
20/12/2004 45,00 45,00 43,00 44,00 +2,80% 4,44% 11.010
17/12/2004 43,00 47,90 40,00 42,80 +2,88% 18,37% 47.140
16/12/2004 42,30 43,00 40,21 41,60 -3,48% 6,60% 4.020
15/12/2004 40,30 44,90 40,00 43,10 +2,38% 12,16% 8.020
14/12/2004 44,10 46,86 42,10 42,10 -3,22% 10,79% 43.310
13/12/2004 38,50 43,90 38,50 43,50 +11,54% 14,03% 53.420
10/12/2004 40,30 40,30 38,00 39,00 -1,27% 5,71% 13.000
09/12/2004 37,00 39,50 35,10 39,50 +7,63% 11,89% 23.020
08/12/2004 32,28 36,80 31,10 36,70 +12,92% 17,66% 19.720
07/12/2004 38,00 38,00 32,10 32,50 -12,16% 15,53% 20.870
06/12/2004 37,90 39,90 35,30 37,00 -2,12% 12,14% 15.050
03/12/2004 40,00 40,90 34,00 37,80 +2,44% 17,25% 48.810
02/12/2004 24,50 49,40 24,50 36,90 +57,02% 101,63% 178.290
01/12/2004 23,80 24,20 23,50 23,50 -0,84% 2,94% 3.140
30/11/2004 25,90 25,90 23,30 23,70 +0,42% 10,04% 4.640
29/11/2004 24,20 24,50 23,30 23,60 -2,48% 4,96% 7.990
26/11/2004 24,00 25,00 24,00 24,20 +4,76% 4,17% 7.810